|
private:iitri
|
533344
|
May 29th, 2019 12:00AM
|
IIT Research Institute (IITRI)
|
2.0K
|
197.00
|
Open
|
Research
|
May 28th, 2019 09:55PM
|
May 28th, 2019 09:55PM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago, with all functions under one roof. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies, and bioanalytical services. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics and are the largest commercial CRO contractor to the National Cancer Institute (NCI).
We provide preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government for rodent, non-rodent and non-human primate (NHP) studies. Our researchers provide specialized expertise in infectious disease, IND-enabling toxicology programs, inhalation toxicology for chemicals or pharmaceuticals, and cancer biology/immunology.
As a mid-size CRO, we provide personalized attention and rapid study start dates. Our PhD/DABT study directors are available for consultation and updates throughout the duration of the study, and we offer flexible study design and adjustments. We look forward to discussing your study with you!
|
Open
|
Inhalation Tox, Safety Pharmacology, DART, Genetic Toxicology, Bioanalytical, Influenza, Pharmacokinetics, Carcinogenicity, Infectious Disease, Xenograft, Bioaerosol, Toxicology, Cancer, Nonclinical, Oncolytic Viruses, Vaccines, E Cigarettes, Smoke Chemistry
|
Open
|
10 West 35th Street
|
Chicago
|
Illinois
|
US
|
60616
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Mar 15th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.6K
|
150.00
|
Open
|
Research
|
Mar 14th, 2018 08:24PM
|
Mar 14th, 2018 08:24PM
|
|
Open
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 17th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 16th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 15th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 14th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 13th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 12th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 11th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
private:iitri
|
533344
|
Feb 10th, 2018 12:00AM
|
IIT Research Institute (IITRI)
|
1.5K
|
136.00
|
Open
|
Research
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
IITRI was founded in 1936 as the research arm of the Illinois Institute of Technology (IIT). IITRI operates as an independent, not-for-profit preclinical contract research organization and research institute. Current facilities include over 110,000 square feet of laboratory space in one location in Chicago. Areas of specialty include preclinical safety and toxicology, inhalation toxicology, biodefense and infectious disease studies. In addition, we have extensive experience evaluating the efficacy and preclinical safety of cancer therapeutics.
IITRI has a long history of providing preclinical safety and toxicology testing services to sponsors from the pharmaceutical, biotechnology, consumer products, and chemical industries, as well as to the U.S. Government. IITRI is also a premier provider of inhalation toxicology services, and has been performing these studies for over 40 years. The strength of IITRI’s program is our knowledge of aerosol science and the ability to generate and characterize well-controlled test atmospheres with various complex test articles.
IITRI established the cancer research program in 1957 to evaluate the efficacy, mechanisms of action and preclinical safety of cancer therapies and chemopreventive agents. IITRI is a leader in cancer drug discovery and development with over 250 publications in the area. In addition, we are the leading preclinical contractor to the NCI for 10 years running.
For more than 40 years, IITRI has provided research and development services to support the U. S. Government’s efforts to defend against the growing threats of bioterrorism and emerging infectious diseases. We have the distinction of being one of only two non-government laboratories that operate a Department of the Army approved Biological Surety Program.
|
|
|
|
|
|
|
|
|
|
IITRI
|
Health Care
|
Pharmaceuticals & Biotechnology
|